Get started
Author

Frida Ewald Sander

Observed names: F E Sander, Frida E. Sander
ORCID: 0000-0002-9726-6344
Observed ORCID: 0000-0002-9726-6344
OpenAlex ID: A5081275633
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
2018 · Hanna Grauers Wiktorin, Malin S. Nilsson, et al. · Cancer Immunology Immunotherapy · 86
PDF
The HLA-B −21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia
2019 · Alexander Hallner, Elin Bernson, et al. · Blood · 63
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
2017 · Frida Ewald Sander, Malin Nilsson, et al. · Cancer Immunology Immunotherapy · 50
PDF
Histamine Promotes the Development of Monocyte-Derived Dendritic Cells and Reduces Tumor Growth by Targeting the Myeloid NADPH Oxidase
2015 · Anna Martner, Hanna G Wiktorin, et al. · The Journal of Immunology · 40
PDF
IκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection
2015 · Michaela Annemann, Zuobai Wang, et al. · The Journal of Immunology · 29
Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML
2019 · Johan Aurelius, Lars Möllgård, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 26
PDF
Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia
2017 · E Bernson, A Hallner, et al. · Leukemia · 19
PDF
c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma
2019 · Tobias Luebke, Lisa Schwarz, et al. · Cell Death and Disease · 18
PDF
Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia
2017 · Anna Rydstroüm, Alexander Hallner, et al. · Journal of Leukocyte Biology · 18
Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia
2016 · Frida Ewald Sander, Anna Rydström, et al. · Oncotarget · 15
PDF
Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2018 · Elin Bernson, Alexander Hallner, et al. · Cancer Immunology Research · 9
Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia
2014 · Alexander Hallner, Johan Aurelius, et al. · European Journal Of Haematology · 4
PDF
Data from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
Supplementary information from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
Supplementary information from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
PDF
Data from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
Impact of HLA-B Dimorphism in the Leader Peptide on Clinical Outcome in AML
2017 · Alexander Hallner, Elin Bernson, et al. · Blood
Abstract CT116: Dynamics of cytotoxic T-cell subsets during immunotherapy predicts outcome in acute myeloid leukemia
2016 · Frida Ewald Sander, Anna Rydström, et al. · Cancer Research
Efficacy of the HOX-inhibitor HXR9 in acute myeloid leukemia Master's Thesis in Medicine
2015 · Emelie Carlsson, Frida Ewald Sander
Works count: 19
Citation count: 377
H-index: 10
I10-index: 10
Year
Topic
Type